Clinical Trial Update: Umbilical Cord Blood Cell (MC001) Transplant Into Injured Spinal Cord Followed by the Locomotor Training [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating umbilical cord blood cell (MC001) transplant into an injured spinal cord followed by locomotor training was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Umbilical Cord Blood Cell (MC001) Transplant

Snippet

Sponsor: StemCyte, Inc. | Conditions: Spinal Cord Injuries | Phase 2 | Status: TERMINATED